Evidence map›Paper›PMID 41233147›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

In Vivo PET Imaging of [

Franziska Zajicek, Filipe Elvas, Alan Miranda, Jordy Akkermans, Jeroen Verhaeghe, Celia Dominguez, Robert Doot, Vinod Khetarpal, Jonathan Bard, Longbin Liu and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Franziska ZajicekMolecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium.
Filipe ElvasMolecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium.
Alan MirandaMolecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium.
Jordy AkkermansMolecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium.
Jeroen VerhaegheMolecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium.
Celia DominguezCHDI Management, Los Angeles, California; and.
Robert DootCHDI Management, Los Angeles, California; and.
Vinod KhetarpalCHDI Management, Los Angeles, California; and.
Jonathan BardCHDI Management, Los Angeles, California; and.
Longbin LiuCHDI Management, Los Angeles, California; and.
Steven StaelensMolecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium.
Daniele BertoglioµNeuro Research Center of Excellence, University of Antwerp, Antwerp, Belgium; daniele.bertoglio@uantwerpen.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aggregation of mutant huntingtin (mHTT) is a neurologic hallmark of Huntington disease (HD), a neurodegenerative disorder caused by the expansion of a cytosine-adenine-guanine repeat tract in the huntingtin gene (

Indexed as

Fluorine RadioisotopesHuntingtin ProteinHuntington DiseaseMutationPositron-Emission TomographyProtein AggregatesAnimalsBrainDisease Models, AnimalLigandsMaleMiceRadiopharmaceuticalsFluorine RadioisotopesHuntingtin ProteinLigandsProtein AggregatesRadiopharmaceuticals[18F]CHDI-385huntingtinHuntington diseasemHTTzQ175DN

Identifiers

PMID41233147
PMCPMC12866408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.